John M Burke, MD

Research Reports

Treatment Pathways for First-Line Metastatic Non-Small Cell Lung Cancer: Cost and Survival

10/21/2020

Lalan Wilfong, MD

Aimee Ginsburg, PharmD, BCPS

J Russell Hoverman, MD, PhD

John M Burke, MD

Leslie T Busby, MD

Angela Hsieh, PharmD, BCOP

Kartik Konduri, MD

Marcus A Neubauer, MD

Abstract: Value Pathways powered by NCCN™ provides oncologists with a list of clinically proven treatment options that support the delivery of high-quality, cost-effective cancer care. We evaluated the economic and...

...

10/21/2020

Journal of Clinical Pathways

Research Reports

Barriers to Lymphoma Clinical Practice Guideline Adherence: A Pilot Mixed-Methods Research Study

04/16/2019

Mihaela C Munteanu, EdD, MS

John M Burke, MD

Abstract: Little is published about adherence barriers to lymphoma clinical practice guidelines (CPGs). This article examines the most frequent barriers to adherence to lymphoma CPGs. An explanatory sequential...

...

04/16/2019

Journal of Clinical Pathways